Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 6/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | PPARG | P37231 | 6/20 | 0.33 |
| ▸ | PPARD | Q03181 | 6/20 | 0.33 |
| ▸ | PPARA | Q07869 | 6/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.33 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.33 |
| ▸ | TLR2 | O60603 | 2/20 | 0.33 |
| ▸ | FABP4 | P15090 | 2/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7883209 | 0.98 | MEN1 (0.40) | MEN1KMT2AGAANAALAD2TDP1 | |
| SCHEMBL7886169 | 0.95 | MEN1 (0.41) | MEN1KMT2AGAANAALAD2TDP1 | |
| SCHEMBL14660314 | 0.83 | CTSK (0.43) | MEN1KMT2AGAATDP1CTSS | |
| SCHEMBL11569761 | 0.81 | TDP1 (0.37) | MEN1KMT2AGAANAALAD2TDP1 | |
| SCHEMBL28235385 | 0.80 | CTSK (0.41) | MEN1KMT2AGAATDP1ALDH1A1 | |
| SCHEMBL11522921 | 0.80 | TSHR (0.44) | MEN1KMT2ANAALAD2TDP1LMNA | |
| SCHEMBL5772332 | 0.78 | MEN1 (0.40) | MEN1KMT2AGAANAALAD2TDP1 | |
| SCHEMBL29747299 | 0.77 | MEN1 (0.38) | MEN1KMT2AGAATDP1CTSS | |
| SCHEMBL7878307 | 0.76 | NAALAD2 (0.38) | MEN1KMT2AGAANAALAD2TDP1 | |
| SCHEMBL23040814 | 0.76 | CTSK (0.39) | MEN1KMT2AGAACTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040138139-A1 | Novel compounds | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LTD (GB) | 2004-07-15 | — | — | US | disclosed |
| EP-1343810-A2 | DIAMINODICARBOXYLIC ACID: PEPTIDE-BASED GEMINI SURFACTANT COMPOUNDS USED FOR DRUG DELIVERY | SmithKline Beecham P.L.C. (GB) | 2003-09-17 | — | — | EP | disclosed |
| WO-2002050100-A2 | DIAMINODICARBOXYLIC ACID: PEPTIDE-BASED GEMINI SURFACTANT COMPOUNDS USED FOR DRUG DELIVERY | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138139-A1 | Novel compounds | GMNN, NGLY1, GLUL | MEN1 1352/4885KMT2A 4725/4885GAA 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.